Investor Presentation • Sep 23, 2024
Investor Presentation
Open in ViewerOpens in native device viewer
INVESTOR PRESENTATION
MUNICH, 23 SEPTEMBER 2024
This presentation contains forward-looking statements.
These statements are based on the current views, expectations and assumptions of the management of Cherry SE and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Actual results, performance or events may differ materially from those described herein due to factors affecting Cherry SE such as, among other things, changes in the general economic and competitive environment, capital market risks, currency exchange rate fluctuations and competition from other companies, and changes in international and national laws and regulations, in particular with respect to tax laws and regulations. Cherry SE does not assume any obligation to update any forwardlooking statements.
The information contained in this presentation is for background purposes only and does not purport to be full or complete. No reliance may be placed, for any purpose, on the information contained herein or its accuracy or completeness. The information in this presentation is subject to change.
This presentation also contains estimates and other statistical data made by independent parties and by the Company relating to the Company's industry, the Company's business and the market for the Company's products and its future growth. This data involves a number of assumptions and limitations, and you are cautioned not to give undue weight to such estimates. In addition, projections, assumptions, and estimates of the Company's future performance and the future performance of the market for its products are necessarily subject to a high degree of uncertainty and risk.
Figures may not add up due to rounding.


Digital Health \& Solutions


Innovation for MX and
ULP product lines as well as development and production of MX2 and ULP switches

Development / manufacturing of System-on-Modules (SoM), Single-Board Computers (SBC) and Full-Custom Design Devices (FCD)

Development and production of office and gaming hardware
Design and development of gaming devices

Oliver Kaltner, CEO
Experienced CEO with proven track record in IT, digital, consumer electronics and branded companies, both in large corporations and SMID as well as start-ups.

Dr. Udo Streller, COO
More than 20 years of management experience in operational excellence, including constructing and managing factories, R\&D, product management, and supply chain management procurement.

FINANCING
SECURED

EARLIER START OF CHINESE ASSEMBLY

HEALTHY INVENTORY LEVELS

DH\&S
PLATFORM
OWNERSHIP

ALIGNMENT OF SALES AND CONTROLLING

"MARGIN OVER
VOLUME" LED TO LFL
SEQUENTIAL INCREASE
IN PROFITABILITY
H1 REVENUE
(in EUR m)

H1 ADJ. EBITDA***
(in EUR m; mgn. in \%)

Back to
competitive pricing
products:

Computex - new
switches:
New volume
customers:

Reach:
New D2C
agreements and
wider distribution
Strategy:
Prioritize margin over market share

Core Market Focus:
Prioritize primary markets
Inventory:
Maintain optimal stock levels

Benefit from progressing digitisation in healthcare
Building up new asset-light revenue streams

75\% market share in new terminal sales
Q2 strongest quarter ever for our Hygiene \& Security unit

New and replacement business
Robust demand and supply management in place
Low Predictability of Container Shipping Availability



TMS
Terminal Management System for remote device management

SMARTLINK
Virtualized patient authentication service: imminent product approval

TI-M
Messenger: certification and launch planned for Q4
Q3 24 REVENUES AROUND EUR 35 M

Q3 2023

Q3 24 ADJ. EBITDA MGN. 5-6\%


2024 REVENUES
EUR 140-150M

2023

2024 ADJ. EBITDA
MGN. 7-8\%

[^0]
[^0]: * Mid point of forecast range

NICOLE SCHILLINGER SVP INVESTOR RELATIONS
EMAIL: [email protected] PHONE: +49 96432061848
WEB: HTTPS://IR.CHERRY.DE
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.